This list is an analysis based on recent market events. It's not an investment recommendation.
About
L&K Biomed Ltd., a medical company, manufactures and sells spinal implants in South Korea, the United States, Thailand, and internationally. The company offers spinal products comprising BlueEX-T, BluEX-TC, BluEX-A, BlueEX-L, and BluEX-ATP; BluEX-LT, an advanced lateral cage system for spinal lordosis restoration; PathLoc-TM, an expandable TLIF/PLIF lumbar cage system; AccelFix-XL, an expandable lateral lumbar cage system; AccelFix-XTP, an expandable lumbar cage system for anterior-to-psoas approach; and PathLoc-TA, an expandable ALIF anterior lumbar cage system. It also provides CastleLoc-C, an anterior cervical interbody fusion cage; CastleLoc-P, an anterior cervical plate system; CastleLoc-S, a posterior cervical fixation system; AccelFix-S, a lumbar spinal fixation screw system; AccelFix-LP, a lumbar plate system; OpenLoc-L, a lumbar spinal fixation system; LnK Lumbar Peek Cages for posterior lumbar interbody fusion procedures; PathLoc-L, a MIS spinal system; AccelFix-MIS, a spinal fixation system; and PathLoc-SI sacroiliac fixation and fusion system that offers fusion and stabilization of the SI joint. In addition, the company offers CastleLoc Pectus bar system for the correction of pectus excavatum. L&K Biomed Ltd. was founded in 2008 and is headquartered in Yongin-si, South Korea.
The current price of 156100.KQ is ₩4,240 KRW — it has increased by +9.84% in the past 24 hours. Watch L&K Biomed stock price performance more closely on the chart.
What is L&K Biomed stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on KOSDAQ exchange L&K Biomed stocks are traded under the ticker 156100.KQ.
Is L&K Biomed stock price growing?▼
156100.KQ stock has risen by +2.42% compared to the previous week, the month change is a +19.94% rise, over the last year L&K Biomed has showed a -45.92% decrease.
What is L&K Biomed market cap?▼
Today L&K Biomed has the market capitalization of 92.37B
What is L&K Biomed revenue for the last year?▼
L&K Biomed revenue for the last year amounts to 38.92B KRW.
What is L&K Biomed net income for the last year?▼
156100.KQ net income for the last year is -16.3B KRW.
In which sector is L&K Biomed located?▼
L&K Biomed operates in the Other sector.
When did L&K Biomed complete a stock split?▼
The last stock split for L&K Biomed was on October 06, 2014 with a ratio of 1.5:1.
Where is L&K Biomed headquartered?▼
L&K Biomed is headquartered in Yongin-si, South Korea.